Humana Inc: Form 10-K for the period ended Dec 31, 2021
Filed with the SEC on Feb 17, 2022 and accepted by EDGAR at Feb 17, 2022, 16:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | $83.06bn | us-gaap:Revenues |
| Selling, general and administrative | 12 months2021-01-01 to 2021-12-31 | $10.12bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-01-01 to 2021-12-31 | $3.15bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-01-01 to 2021-12-31 | $326.0m | us-gaap:InterestExpense |
| Income tax | 12 months2021-01-01 to 2021-12-31 | $485.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-01-01 to 2021-12-31 | $2.93bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | $22.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | $22.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-01-01 to 2021-12-31 | 129,396,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | $2.26bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | $1.32bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2021-01-01 to 2021-12-31 | $90.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2021-01-01 to 2021-12-31 | $79.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-12-31 | $3.39bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-12-31 | $24.89bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | $44.36bn | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | $15.33bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-12-31 | $28.25bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-12-31 | $10.54bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-12-31 | $1.95bn | us-gaap:DebtCurrent |
Source: SEC EDGAR, the filing index for accession 0000049071-22-000017. Last ingested by Listed: Nov 6, 2026, 14:15 ET. Listed shows no prices and gives no investment advice.